Ip, Andrew
Mutebi, Alex
Wang, Tongsheng
Jun, Monika
Kalsekar, Anupama
Navarro, Fernando Rivas
Wang, Anthony
Kamalakar, Rajesh
Sacchi, Mariana
Elliott, Brian
Funding for this research was provided by:
Genmab
AbbVie
Article History
Received: 28 September 2023
Accepted: 15 December 2023
First Online: 2 February 2024
Declarations
:
: Andrew Ip: Honoraria: Pfizer; Speakers Bureau: Seagen; Advisory Board: Secura Bio, AstraZeneca, TG Therapeutics; Equity Interest: COTA. Alex Mutebi, Tongsheng Wang, Monika Jun, Anupama Kalsekar, Fernando Rivas Navarro, Mariana Sacchi, and Brian Elliott: Employees of Genmab and own stock. Anthony Wang and Rajesh Kamalakar: Employees of AbbVie and own stock.
: Given that the COTA database houses de-identified, secondary data, this analysis did not require Institutional Review Board approval. All authors had full permission to access and use the COTA EHR database for this study.